Join
Live feed
·
PRReleasevia Quantisnow
Prelude Therapeutics Incorporated logo

Prelude Therapeutics Announces Publication of Abstract for Presentation at the European Society of Medical Oncology (ESMO) Congress 2024

ByQuantisnow·Wall Street's wire, on your screen.
PRLD· Prelude Therapeutics Incorporated
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRLD (Prelude Therapeutics Incorporated) and more on Quantisnow.